Clinical Trials Logo

Filter by:
NCT ID: NCT04272749 Active, not recruiting - Consumer Behavior Clinical Trials

Consumer Perceptions of Milk Beverages

CMK2
Start date: December 16, 2019
Phase: N/A
Study type: Interventional

The objectives of this study are to: 1. Investigate and describe perceptions of nutrient content, including calories, of plant-based milks and dairy milks without food labels (ie., no Ingredient or Nutrition Facts label) and how this impacts consumption choice. 2. Determine understanding of nutrient content, including calories, of plant-based milks and dairy milks after given access to food labels (ie., Ingredient or Nutrition Facts label) and how this impacts consumption choice. 3. Assess influence of age, gender, economic status, and race/ethnicity on results.

NCT ID: NCT04272606 Active, not recruiting - Clinical trials for Degenerative Disc Disease

TXA in Spinal Fusion

Start date: August 1, 2020
Phase: Phase 2
Study type: Interventional

Tranexamic acid and placebo will be given during surgery to patients who have elected to undergo lumber interbody fusion on 2 or more levels. Information regarding blood loss, transfusions needed, postoperative cognitive status (including delirium), postoperative markers of systemic inflammation and duration of hospital stay will be collected.

NCT ID: NCT04272034 Active, not recruiting - Cervical Cancer Clinical Trials

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Start date: March 26, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of INCB099318 in select solid tumors.

NCT ID: NCT04271709 Active, not recruiting - Cataract Clinical Trials

Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

Start date: September 30, 2019
Phase: N/A
Study type: Interventional

The investigators are conducting a 5-year prospective, cluster-randomized controlled trial, funded by the Centers for Disease Control (CDC), which provides vision screenings to underserved, vulnerable New York City residents living in affordable housing buildings in Harlem and Washington Heights.

NCT ID: NCT04271358 Active, not recruiting - Clinical trials for Congenital Heart Disease

Peer Coaching Intervention in Young Adults With Congenital Heart Disease

CHASM in ACHD
Start date: October 8, 2020
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate a peer coaching intervention in young adults with congenital heart disease.

NCT ID: NCT04271332 Active, not recruiting - Clinical trials for 16P11.2 Deletion Syndrome

Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion

Start date: September 1, 2022
Phase: Phase 2
Study type: Interventional

This Phase 2 study examines the safety, tolerability, and efficacy of arbaclofen in pediatric subjects with 16p11.2 deletion. Male or female subjects aged 5 to 17 years of age will be randomized to receive either placebo or arbaclofen in a double-blind study design. If the subject completes all study requirements through Visit 4 (Close-out Visit), he/she may be eligible for an optional open-label study with arbaclofen.

NCT ID: NCT04271319 Active, not recruiting - Clinical trials for Carpal Tunnel Syndrome

Avazzia HVPC Bio-Electrical Stimulation Technology (BESTâ„¢) Microcurrent CTS RCT

Start date: September 14, 2020
Phase: N/A
Study type: Interventional

A clinical study at Activated Family Chiropractic & Wellness, is being proposed to test the efficacy of a novel electrical stimulation platform named the Pro-Sport Ultra® designed by AVAZZIA to relieve pain and improve mobility in patients with Carpal Tunnel Syndrome (CTS).

NCT ID: NCT04271202 Active, not recruiting - Chronic Migraine Clinical Trials

Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action

Start date: July 29, 2020
Phase: Phase 4
Study type: Interventional

The purpose of this study is to understand better the mechanisms of action of calcitonin gene related peptide (CGRP) targeted monoclonal antibodies in migraine prevention. Specifically, the protocol will allow the investigators to determine whether the main site of action of this novel and recently-approved class of migraine prophylactic drugs act inside or outside the brain and if so, where.

NCT ID: NCT04271163 Active, not recruiting - Alzheimer's Disease Clinical Trials

Transcranial Electromagnetic Treatment (TEMT) Against Alzheimer's Disease

Start date: February 10, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is a second extension of EM 1000-1 wherein mild/moderate AD subjects who participated in the original study have completed participation in a first extension of 4-months. Most of the eight subjects in the original EM 1000-1 and first extension agreed to participate in this second extension study. The time between completion of the first extension and the second extension is 4 months. This second extension study;'s primary objective is to determine the long-term safety and efficacy of 12 months of daily treatment on performance of these AD subjects in the same comprehensive array of cognitive tasks as they performed in the initial 2-month study and 4-month first extension.Secondary objectives include analysis of blood for AD markers and evaluation of safety throughout the treatment period. Upon completion of this 12-month extension, the period between initial treatment and final treatment will be 2-3 years.

NCT ID: NCT04270604 Active, not recruiting - Cancer Clinical Trials

Biological Sample Collection for Research and Biobanking

Start date: February 6, 2012
Phase:
Study type: Observational

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to study different conditions and diseases by using cells from the body (such as skin or blood cells). NYSCF uses these samples to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store these samples for future use. Through this research, scientists hope to identify future treatments or even cures.